EDSA
Edesa Biotech, Inc.$3.53-0.13 (-3.55%)Prev Close$3.66·MCap$93.2M·P/E—·Vol26.9K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
0
$0.00
◆
Net Activity
Net Buyer
$0.00
●
Active Insiders
0
last 12 mo
EDSA Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 25, 2024 | Nijhawan Pardeep | Chief Executive Officer | Buy | 5,000 | $4.00 | $20.0K | 0 |
| Jan 9, 2023 | van der Velden Peter | 10% Owner | Sell | 297,474 | $2.65 | $787.7K3.6% OS | 0 |
| Jun 30, 2022 | Nijhawan Pardeep | Chief Executive Officer | Buy | 20,000 | $1.60 | $32.1K | 0 |
| Jun 29, 2022 | Brooks Michael J | President | Buy | 3,000 | $1.49 | $4.5K | 0 |
| Jun 16, 2022 | Brooks Michael J | President | Buy | 3,000 | $1.61 | $4.8K | 0 |
| May 27, 2022 | Nijhawan Pardeep | Chief Executive Officer | Buy | 5,000 | $1.92 | $9.6K | 0 |
| May 25, 2022 | Brooks Michael J | President | Buy | 3,500 | $1.74 | $6.1K | 0 |
| May 24, 2022 | Nijhawan Pardeep | Chief Executive Officer | Buy | 2,000 | $1.80 | $3.6K | 0 |
| Mar 31, 2022 | Nijhawan Pardeep | Chief Executive Officer | Buy | 2,000 | $2.99 | $6.0K | 0 |
| Mar 30, 2022 | Nijhawan Pardeep | Chief Executive Officer | Buy | 2,000 | $3.05 | $6.1K | 0 |
| Mar 29, 2022 | Nijhawan Pardeep | Chief Executive Officer | Buy | 2,000 | $3.02 | $6.0K | 0 |
| Mar 18, 2022 | Nijhawan Pardeep | Chief Executive Officer | Buy | 2,000 | $3.85 | $7.7K | 0 |
| Mar 17, 2022 | Nijhawan Pardeep | Chief Executive Officer | Buy | 2,000 | $3.26 | $6.5K | 0 |
| Mar 15, 2022 | Nijhawan Pardeep | Chief Executive Officer | Buy | 2,000 | $2.80 | $5.6K | 0 |
| Mar 14, 2022 | Brooks Michael J | President | Buy | 1,250 | $2.79 | $3.5K | 0 |
| Mar 11, 2022 | Nijhawan Pardeep | Chief Executive Officer | Buy | 7,000 | $3.09 | $21.7K | 0 |
| Mar 10, 2022 | Brooks Michael J | President | Buy | 1,000 | $3.22 | $3.2K | 0 |
| Mar 9, 2022 | Nijhawan Pardeep | Chief Executive Officer | Buy | 1,500 | $3.05 | $4.6K | 0 |
| Mar 8, 2022 | Brooks Michael J | President | Buy | 1,250 | $2.90 | $3.6K | 0 |
| Mar 29, 2021 | Nijhawan Pardeep | Chief Executive Officer | Buy | 2,000 | $5.23 | $10.5K | 0 |
| Mar 25, 2021 | Brooks Michael J | President | Buy | 3,500 | $5.19 | $18.2K | 0 |
| Mar 25, 2021 | Nijhawan Pardeep | Chief Executive Officer | Buy | 3,000 | $5.25 | $15.8K | 0 |
| Mar 24, 2021 | Brooks Michael J | President | Buy | 4,500 | $5.08 | $22.9K | 0 |
| Mar 24, 2021 | Nijhawan Pardeep | Chief Executive Officer | Buy | 5,000 | $5.16 | $25.8K | 0 |
EDSA Insider Buying Activity
The following table shows recent insider purchases of Edesa Biotech, Inc. (EDSA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 25, 2024 | Nijhawan Pardeep | Chief Executive Officer | Buy | 5,000 | $4.00 | $20.0K | 0 |
| Jun 30, 2022 | Nijhawan Pardeep | Chief Executive Officer | Buy | 20,000 | $1.60 | $32.1K | 0 |
| Jun 29, 2022 | Brooks Michael J | President | Buy | 3,000 | $1.49 | $4.5K | 0 |
| Jun 16, 2022 | Brooks Michael J | President | Buy | 3,000 | $1.61 | $4.8K | 0 |
| May 27, 2022 | Nijhawan Pardeep | Chief Executive Officer | Buy | 5,000 | $1.92 | $9.6K | 0 |
| May 25, 2022 | Brooks Michael J | President | Buy | 3,500 | $1.74 | $6.1K | 0 |
| May 24, 2022 | Nijhawan Pardeep | Chief Executive Officer | Buy | 2,000 | $1.80 | $3.6K | 0 |
| Mar 31, 2022 | Nijhawan Pardeep | Chief Executive Officer | Buy | 2,000 | $2.99 | $6.0K | 0 |
| Mar 30, 2022 | Nijhawan Pardeep | Chief Executive Officer | Buy | 2,000 | $3.05 | $6.1K | 0 |
| Mar 29, 2022 | Nijhawan Pardeep | Chief Executive Officer | Buy | 2,000 | $3.02 | $6.0K | 0 |
| Mar 18, 2022 | Nijhawan Pardeep | Chief Executive Officer | Buy | 2,000 | $3.85 | $7.7K | 0 |
| Mar 17, 2022 | Nijhawan Pardeep | Chief Executive Officer | Buy | 2,000 | $3.26 | $6.5K | 0 |
| Mar 15, 2022 | Nijhawan Pardeep | Chief Executive Officer | Buy | 2,000 | $2.80 | $5.6K | 0 |
| Mar 14, 2022 | Brooks Michael J | President | Buy | 1,250 | $2.79 | $3.5K | 0 |
| Mar 11, 2022 | Nijhawan Pardeep | Chief Executive Officer | Buy | 7,000 | $3.09 | $21.7K | 0 |
| Mar 10, 2022 | Brooks Michael J | President | Buy | 1,000 | $3.22 | $3.2K | 0 |
| Mar 9, 2022 | Nijhawan Pardeep | Chief Executive Officer | Buy | 1,500 | $3.05 | $4.6K | 0 |
| Mar 8, 2022 | Brooks Michael J | President | Buy | 1,250 | $2.90 | $3.6K | 0 |
| Mar 29, 2021 | Nijhawan Pardeep | Chief Executive Officer | Buy | 2,000 | $5.23 | $10.5K | 0 |
| Mar 25, 2021 | Brooks Michael J | President | Buy | 3,500 | $5.19 | $18.2K | 0 |
| Mar 25, 2021 | Nijhawan Pardeep | Chief Executive Officer | Buy | 3,000 | $5.25 | $15.8K | 0 |
| Mar 24, 2021 | Brooks Michael J | President | Buy | 4,500 | $5.08 | $22.9K | 0 |
| Mar 24, 2021 | Nijhawan Pardeep | Chief Executive Officer | Buy | 5,000 | $5.16 | $25.8K | 0 |
EDSA Insider Selling Activity
The following table shows recent insider sales of Edesa Biotech, Inc. (EDSA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 9, 2023 | van der Velden Peter | 10% Owner | Sell | 297,474 | $2.65 | $787.7K3.6% OS | 0 |
EDSA Insiders
Similar Stocks to EDSA
REGN
Regeneron Pharmaceuticals, Inc.
$746.00+0.87%
$75.74B
MRNA
Moderna, Inc.
$222.08+12.69%
$75.39B
RVMD
Revolution Medicines, Inc.
$189.39+0.66%
$43.93B
ALNY
Alnylam Pharmaceuticals, Inc.
$232.11+3.48%
$29.40B
INSM
Insmed Incorporated
$100.45-0.04%
$24.09B
INCY
Incyte Corporation
$113.13+0.34%
$23.37B
UTHR
United Therapeutics Corporation
$550.30+3.28%
$22.77B
EXEL
Exelixis, Inc.
$60.27+2.12%
$14.79B